Alexey Lugovskoy, Ph.D.President and CEO at Diagonal TherapeuticsSpeaker
Profile
Alex is the CEO of Diagonal Therapeutics and Entrepreneur-in-Residence at Atlas Venture. During his 20+ year career in biotechnology, he served as COO of Dragonfly Therapeutics, CDO of Morphic Therapeutic, VP of Therapeutics at Merrimack Pharmaceuticals, and Associate Director of Drug Discovery at Biogen. Alex is an author of over 100 patents and manuscripts and an Associate Editor of the mAbs, a journal dedicated to the art and science of antibody R&D.
He has received an Advanced Certificate for Executives in Management, Innovation and Technology from MIT Sloan School of Management, a Ph.D. in Biophysics from Harvard University, an M.Sc. in Molecular Biophysics, and a B.Sc. in Mathematics and Physics from the Moscow Institute of Physics and Technology.
Agenda Sessions
Tackling the Impossible Task of Project Selection in An Early Stage Biotech Startup
, 3:15pmView SessionDiscovery and Development of an Antibody Agonist Leveraging Experimental and Computational Methods
, 10:30amView Session